Long-Term Apremilast Promising for Psoriatic Arthritis
Upadacitinib Promising for RA Patients
Results from Belimumab Safety Study
FDA Approves Combination Therapy for OA Pain, but Not Duobrii Lotion for Plaque Psoriasis
FDA Approves Baricitinib for RA Patients
Disease-Modifying Antirheumatic Drugs Cut RA Risk
Certolizumab Pegol Receives FDA Approval for Plaque Psoriasis
Targeted Rheumatoid Arthritis Treatment Does Not Improve Mental Health
AbbVie’s RA Drug Succeeds in Late Stage Study
- 1
- 2
- 3
- …
- 14
- Next Page »